Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
P2P Loan
Grow your wealth in fiat investment
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
Stock CFD Derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
tag
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
IPO
2026 World Cup
Rewards

CJ제일제당 Bio Division Operating Profit Surges to 66-69B Won in Q2, Up 10-Fold from Q1

GateNews
According to Shinhan Securities and other financial firms, CJ제일제당's bio division operating profit surged to 660-690 billion won in Q2 2026, jumping more than ten-fold from 55 billion won in Q1, with operating margin expanding to 5-6% from 0.6%. The recovery was primarily driven by rising international methionine prices—a key amino acid used in poultry feed produced by few manufacturers—and elevated soybean meal costs, which supported both volume and pricing for feed amino acids. The bio division had faced severe headwinds since late 2025 due to increased competition in arginine and tryptophan and renewed inflows of Chinese lysine to Europe.
View Source
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.

Related News

8h ago
KOSPI Q2 Operating Profit Hits 227.7 Trillion Won, Up 234% Year-over-Year
19h ago
China Taihei Futures Raises H1 2026 Profit Guidance to 190%-210% Growth
07-15 00:23
CJ ENM Q2 Operating Profit Forecast 33.4 Billion Won, Up 16.91% YoY
07-15 00:16
HD Hyundai Posts Q2 Operating Profit of 960.1B Won, Up 103.64% Year-on-Year
07-14 23:21
Zhaoyuan Pharma (06127) Projects H1 Net Profit Up 885%-1377%, CXO Sector Backed by Drug Export Surge
In-Depth Analysis

KOSPI Q2 Operating Profit Forecast Hits 227.7 Trillion Won, Korean Stocks Earnings Surge 234% YoY

Lucas Bennett8h ago

KB Securities Forecasts LG Innotek H2 Earnings Surprise, Maintains Buy Rating

Lucas Bennett9h ago

CJ ENM Q2 Forecast Misses Expectations Despite 16.91% Profit Gain

Lucas Bennett07-15 00:24
Comment
0/400
No comments